HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shinne-Ren Lin Selected Research

Diamines

9/2009Novel indoloquinoline derivative, IQDMA, induces G(2)/M phase arrest and apoptosis in A549 cells through JNK/p38 MAPK signaling activation.
11/2008Novel indoloquinoline derivative, IQDMA, inhibits STAT5 signaling associated with apoptosis in K562 cells.
10/2007Involvement of c-Jun N-terminal kinase in G2/M arrest and FasL-mediated apoptosis induced by a novel indoloquinoline derivative, IQDMA, in K562 cells.
11/2006A novel indoloquinoline derivative, IQDMA, induces S-phase arrest and apoptosis in promyelocytic leukemia HL-60 cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shinne-Ren Lin Research Topics

Disease

25Neoplasms (Cancer)
03/2016 - 03/2006
12Leukemia
04/2015 - 04/2005
11Breast Neoplasms (Breast Cancer)
03/2016 - 02/2010
5Neoplasm Metastasis (Metastasis)
03/2016 - 11/2011
5Neuroblastoma
09/2010 - 03/2008
3Squamous Cell Carcinoma of Head and Neck
09/2010 - 10/2009
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
05/2014 - 10/2009
2Prostatic Neoplasms (Prostate Cancer)
03/2010 - 03/2006
2Adenocarcinoma of Lung
01/2010 - 09/2009
1Lung Neoplasms (Lung Cancer)
12/2015
1Mouth Neoplasms (Oral Cancer)
01/2013
1Hepatocellular Carcinoma (Hepatoma)
09/2010
1Carcinoma (Carcinomatosis)
03/2010
1Hemolysis
09/2009
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
04/2006
1Colorectal Neoplasms (Colorectal Cancer)
03/2006

Drug/Important Bio-Agent (IBA)

11CardiotoxinsIBA
01/2013 - 04/2005
7p38 Mitogen-Activated Protein KinasesIBA
04/2015 - 07/2008
7N-formyl-13-dihydrocarminomycin (NFD)IBA
09/2014 - 01/2010
5VenomsIBA
03/2016 - 06/2007
5furanIBA
02/2014 - 01/2010
4Cobra Cardiotoxin ProteinsIBA
03/2016 - 08/2008
4Peptides (Polypeptides)IBA
03/2016 - 06/2007
4Phospholipases A2 (Phospholipase A2)IBA
12/2014 - 07/2008
4ErbB Receptors (EGF Receptor)IBA
02/2013 - 03/2006
4Phospholipases (Phospholipase)IBA
11/2011 - 01/2009
4DiaminesIBA
09/2009 - 11/2006
4Antineoplastic Agents (Antineoplastics)IBA
11/2008 - 11/2006
3Epidermal Growth Factor (EGF)IBA
03/2016 - 06/2010
3Pharmaceutical PreparationsIBA
12/2015 - 06/2007
2Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
09/2014 - 08/2014
2NF-kappa B (NF-kB)IBA
09/2010 - 01/2009
2Paclitaxel (Taxol)FDA LinkGeneric
03/2010 - 03/2006
2Caspase 3 (Caspase-3)IBA
11/2009 - 08/2006
2Amino AcidsFDA Link
10/2009 - 06/2007
2Reactive Oxygen Species (Oxygen Radicals)IBA
08/2008 - 03/2008
2CaspasesIBA
06/2007 - 03/2006
1Irinotecan (Camptosar)FDA LinkGeneric
12/2015
1Topotecan (Hycamtin)FDA LinkGeneric
12/2015
1quinolineIBA
12/2015
1Quinacrine (Mepacrine)IBA
04/2015
1notexinIBA
12/2014
1furano-1,2-naphthoquinoneIBA
05/2014
1Protein Phosphatase 2 (Protein Phosphatase 2A)IBA
09/2013
1Caffeine (No Doz)FDA LinkGeneric
09/2013
1brazileinIBA
07/2013
1Matrix Metalloproteinases (MMPs)IBA
01/2013
1Snake Venoms (Snake Venom)IBA
01/2013
1WortmanninIBA
01/2012
1SB 203580IBA
01/2012
1DiterpenesIBA
11/2011
1cembraneIBA
11/2011
1ovatodiolideIBA
11/2011
1src-Family KinasesIBA
09/2010
1chloroacetaldehydeIBA
06/2010
1lawsoneIBA
06/2010
1epigallocatechin gallate (epigallocatechin-3-gallate)IBA
03/2010
1GenisteinIBA
03/2010
1IsoflavonesIBA
03/2010
1pyrrolidine dithiocarbamic acidIBA
03/2010
1Hormones (Hormone)IBA
03/2010
1Taxoids (Taxanes)IBA
03/2010
1TeaIBA
03/2010
1AntioxidantsIBA
03/2010
1Vitamin EFDA LinkGeneric
03/2010
1Cytochromes c (Cytochrome c)IBA
11/2009
1Mitogen-Activated Protein KinasesIBA
09/2009
1CholesterolIBA
09/2009
1PhosphatidylserinesIBA
01/2009
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
01/2009
1Cyclin D1IBA
11/2008
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2008
1Mitogen-Activated Protein Kinase 3IBA
11/2008
14- (4- dihexadecylaminostyryl)- N- methylpyridium (DiA)IBA
10/2008
1aniline (aniline hydrobromide)IBA
08/2008
1EnediynesIBA
07/2007
1Naja naja atra cardiotoxin IIIIBA
06/2007
1AcidsIBA
06/2007
1JNK Mitogen-Activated Protein KinasesIBA
06/2007
1Proteins (Proteins, Gene)FDA Link
06/2007
1(Z)- 2- (6- (thieanisyl- 2- yl)hexa- 3- en- 1,5- diynyl)benzenamineIBA
02/2007
1GTP-Binding Proteins (G-Protein)IBA
08/2006
1squamocinIBA
04/2006
1AndrogensIBA
03/2006
1PD168393IBA
03/2006
1VA 061 (VA061)IBA
03/2006
1Gefitinib (Iressa)FDA Link
03/2006

Therapy/Procedure

2Therapeutics
01/2013 - 03/2010
1Aftercare (After-Treatment)
07/2008